Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

Femme et Homme

| Pays :
Australia
Singapore
| Organes :
| Spécialités :

Extrait

The objective of the study is to evaluate the immunogenicity and safety of prime-boost vaccination schedule of GSK Biologicals' investigational vaccine GSK1562902A.

Critère d'inclusion

Influenza

Liens

ictrp
nct
gsk